Walter Menzel
Fondateur chez Prostate Management Diagnostics, Inc.
Fortune : 14 993 $ au 30/04/2024
Profil
Walter B.
Menzel is the founder of Prostate Management Diagnostics, Inc., Peter Michael Foundation.
He is currently the President of WM Group.
Previously, he worked as an Independent Director at Cyanotech Corp.
and as a Senior Vice President at McCann-Erickson USA, Inc. Mr. Menzel's education includes a graduate degree in MBA from Stanford University and an undergraduate degree from the University of Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYANOTECH CORPORATION
0,57% | 26/06/2023 | 39 455 ( 0,57% ) | 14 993 $ | 30/04/2024 |
Postes actifs de Walter Menzel
| Sociétés | Poste | Début |
|---|---|---|
| WM Group | President | - |
Peter Michael Foundation
 Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Fondateur | - |
Prostate Management Diagnostics, Inc.
 Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Fondateur | - |
Anciens postes connus de Walter Menzel
| Sociétés | Poste | Fin |
|---|---|---|
McCann-Erickson USA, Inc.
 McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
| CYANOTECH CORPORATION | Directeur/Membre du Conseil | - |
Formation de Walter Menzel
| Stanford University | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYANOTECH CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Prostate Management Diagnostics, Inc.
Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Health Technology |
McCann-Erickson USA, Inc.
McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Commercial Services |
| WM Group | |
Peter Michael Foundation
Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Commercial Services |